Australian and New Zealand Journal of Medicine · 1982 · 36 citations · 7 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyGynecologic OncologyCancer Survival AnalysisCombination ChemotherapyCytotoxic ChemotherapyOvarian CancerOvarian Cancer PharmacotherapyCyclophosphamide-based TherapyOvarian Cancer ChemotherapyOvarian Cancer Clinical TrialsOvarian Cancer Treatment
Abstract: Advanced ovarian cancer: a prospective randomised trial of chlorambucil versus combined cyclophosphamide and cis-diamminedichloroplatinum. D. R. Bell, R. L. Woods, J. A. Levi, R. M. Fox and M. H. N. Tattersall, Aust. N.Z. J. Med., 1982,12, pp. 245–249. Thirty-seven patients with advanced ovarian cancer were treated in a prospective, randomised trial comparing chlorambucil with a combination of cyclophosphamide and cis-diamminedichloroplatinum (cis DDP). Treatment with the combination was associated with an increased overall response rate (69% versus 23%) (p = 004). A response was associated with a longer median survival but no survival advantage was demonstrated for patients who received cyclophosphamide/cis DDP. A larger study is needed to evaluate fully the potential of regimens containing cis DDP in the management of advanced ovarian cancer.
7
Advanced Ovarian Adenocarcinoma
Robert C. Young, Bruce A. Chabner, Susan P. Hubbard et al. · New England Journal of Medicine · 1978 · 322 citations
Medicine, Oncology, Pharmacology +16
Epithelial Carcinoma of the Ovary: Current Strategies
Martin Katz · Annals of Internal Medicine · 1981 · 96 citations
Chemotherapy of ovarian cancer. New Approaches to Treatment
Julian P. Smith, Felix N. Rutledge, J. Taylor Wharton · Cancer · 1972 · 91 citations
Diagnosis and staging of ovarian carcinoma.
Day Tg, Smith Jp · PubMed · 1975 · 58 citations
Medicine, Gynecology, Oncology +12